Why do so many clinical trials of therapies for Alzheimer's disease fail?

Authors	Roy M Anderson, Christoforos Hadjichrysanthou, Stephanie Evans, Mei Mei Wong
Journal	Lancet (London, England) (Lancet) Vol. 390 Issue 10110 Pg. 2327-2329 (Nov 25 2017) ISSN: 1474-547X [Electronic] England
PMID	29185425 (Publication Type: Journal Article)
Chemical References	Antipsychotic Agents
Topics	Aged Aged, 80 and over Alzheimer Disease (diagnosis, drug therapy) Antipsychotic Agents (therapeutic use) Clinical Trials as Topic Female Humans Male Risk Assessment Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!